Type 2 diabetes in people of South Asian origin: potential strategies for prevention

Abstract

South Asians have a one in three lifetime risk for the development of diabetes, developing the condition ten years earlier than Europids. The high social and economic burden of diabetes in South Asians is augmented by greater rates of attrition from renal and cardiovascular disease. This article reviews the epidemiology and pathogenesis of diabetes in South Asians, and potential strategies by which the condition could be prevented or delayed in this high risk group.

Keywords

diabetes prevention South Asian.

Get full access to this article

View all access options for this article.

References

The DECODA study group. Age and sex-specific prevalence of diabetes and impaired glucose regulation in 11 Asian cohorts. Diabetes Care 2003;26:1770-80.

Mather HM , Keen H. Southall Diabetes Survey: prevalence of known diabetes. BMJ 1985;291:1081-4.

Riste L. , Khan F. , Cruickshank K. High prevalence of type 2 diabetes in all ethnic groups, including Europeans in a British Inner City. Relative poverty, history, inactivity or 21st century Europe? Diabetes Care 2001;24:1377-83.

Gupta R. , Misra A. Type 2 diabetes in India: regional disparities. Br J Diab Vas Dis 2007;7:12-16.

Ramachandran A. , Snehalatha C. , Kapur A. et al. Diabetes Epidemiology Study in India (DESI). High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia 2001;44:1094-101.

Mather HM , Chaturvedi N. , Fuller JH Mortality and morbidity from diabetes in South Asians and Europeans: 11 year follow-up of the Southall Diabetes Survey, London, UK. Diabetic Med 1998;15:53-9.

Burden AC , McNally PG , Feehally J. , Walls J. Increased incidence of end-stage renal failure secondary to diabetes mellitus in Asian ethnic groups in the United Kingdom. Diabetic Med 1992;9:641-5.

McKeigue PM , Shah B. , Marmot MG Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991;337:382-6.

Stocker CJ , Arch JR , Cawthorne MA Fetal origins of insulin resistance and obesity. Proc Nutr Soc 2005;64:143-51.

10.

Yajnik CS , Lubree HG , Rege SS et al. Adiposity and hyperinsulinaemia in Indians are present at birth . J Clin Endo Metab 2002;87:5575-80.

11.

Saxena S. , Ambler G. , Cole TJ , Majeed A. Ethnic group differences in overweight and obese children and young people in England: cross sectional survey. Arch Dis Child 2004;89:30-6.

12.

Whincup PH , Gilg JA , Owen CG et al. British South Asians aged 13-16 years have higher fasting glucose and insulin levels than Europeans. Diabetic Med 2005;22:1275-7.

13.

Ehtisham S. , Crabtree N. , Clark P. et al. Ethnic differences in insulin resistance and body composition in United Kingdom adolescents. J Clin Endo Metab 2005 ;90 :3963-9.

14.

Snehalatha C. , Viswanathan V. , Ramachandran A. Cut-off Values for Normal Anthropometric Variables in Asian Indian Adults. Diabetes Care 2003 ;26:1380-4.

15.

WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy populations and its implications for policy and intervention strategies . Lancet 2004;363:157-63. worldwide definition. Lancet 2005;366:1059-61.

16.

Alberti Kgmm , Zimmet P. , Shaw J. The metabolic syndrome -a new worldwide definition , Lancet 2005;366:1059-61.

17.

Snehalatha C. , Mukesh B. , Simon M. et al. Plasma adiponectin is an independent predictor of type 2 diabetes in Asian Indians. A Diabetes Care 2003;26:3226-9.

18.

Viswanathan V. , Snehalatha C. , Nair MB , Ramachandran A. Markers of endothelial dysfunction in hyperglycaemic Asian endothelial dysfunction in hypergly caemic Asian Indian subjects. J Diab Comp 2004;18:47-52.

19.

Mohan V. , Deepa R. , Velmurugan K. , Premalatha G. Association of C-reactive protein with body fat, diabetes and coronary artery disease in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-6) . Diabetic Med 2005;22:863-70.

20.

McCarthy M. , Hitman GA , Shields DC et al. Family studies of non-insulin-dependent diabetes mellitus in South Indians. Diabetologia 1994;37:1221-30.

21.

Davey G. , Ramachandran A. , Snehalatha C. et al. Familial aggregation of central obesity in Southern Indians . Int J Obes Relat Metab Disord 2000;11:1523-7.

22.

Abate N. , Chandalia M. , Satija P. et al. ENPP1/PC-1 K121Q polymorphism and genetic susceptibility to type 2 diabetes. Diabetes 2005;54:1207-13.

23.

Health survey for England 2004: The health of minority ethnic groups. http://www.ic.nhs.uk/pubs/hlthsvyeng2004ethnic/HSE2004Headlineresults.pdf/file. (Accessed 08.11.07).

24.

Lawton J. , Ahmad N. , Hanna L. et al. "I can't do any serious exercise": barriers to physical activity amongst people of Pakistani and Indian origin with type 2 diabetes. Health Educ Res 2006;21:43-54.

25.

Boucher BJ

Inadequate vitamin D status: does it contribute to the disorders comprising syndrome 'X'?

Br J Nutr 1998;79:15-27.

26.

Ogunkolade WB , Boucher BJ , Bustin SA et al. Vitamin D metabolism in peripheral blood mononuclear cells is influenced by chewing "betel nut" (Areca catechu) and vitamin D status. J Clin Endocrinol Metab 2006;91:2612-17.

27.

Eliasson B. Cigarette smoking and diabetes. Progress in Cardiovascular Diseases 2003;45:405-13.

28.

Pan XR , Li GW , Hu YH et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997;20:537-44.

29.

Knowler WC , Barrett-Connor PH , Fowler SE et al. Reduction in the incidence of Type 2 Diabetes with lifestyle intervention or metformin. Diabetes Prevention Programme Research Group. N Engl J Med 2002;346:393-403.

30.

Laaksonen DE , Lindstrom J. , Lakka TA et al. Finnish diabetes prevention study. Physical activity in the prevention of type 2 diabetes: the Finnish diabetes prevention study. Diabetes 2005;54:158-65.

31.

Chiasson JL , Josse RG , Gomis R. et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 2002;359:2072-7.

32.

Buchanan TA , Xiang AH , Peters RK et al. Preservation of pancreatic beta-cell function and prevention of Type 2 diabetes by pharmacological treatment of insulin resistance in high risk Hispanic women. Diabetes 2002;51:2796-803.

33.

DREAM Trial Investigators. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial . Lancet 2006;368:1096-105.

34.

Torgerson JS , Hauptman J. , Boldrin M. , Sjostrom L. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004;27:155-61.

35.

Yusuf S. , Gerstein H. , Hoogwerf B. et al. HOPE study investigators. Ramipril and the development of diabetes . JAMA 2001;286:1882-5.

36.

Lindholm LH , Ibsen H. , Borch-Johnsen K. et al. Risk of new onset diabetes in the Losartan Intervention for End point reduction in hypertension study. J Hypertension 2002;20:1879-86.

37.

Freeman DJ , Norrie J. , Sattar N. et al. Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Circulation 2001;103:57-62.

38.

Actos Now for Prevention of Diabetes (ACT NOW). http://clinicaltrials.gov/show/NCT00220961. (Access at 08.11.07)

39.

The NAVIGATOR trial steering committee. NAVIGATOR trial screening suggests that abnormal glucose tolerance is common in people at risk for cardiovascular disease (Abstract). Diabetes 2003;52(suppl 2):A505.

40.

The ORIGIN trial. http://www.clinicaltrials.gov/ct/show/NCT00069784 (Accessed 08.11.07)

41.

Ramachandran A. , Snehalatha C. , Mary S. et al. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1) . Diabetologia 2006;49:289-97.

42.

Park PJ , Griffin SJ , Sargeant L. , Wareham NJ The performance of a risk score in predicting undiagnosed hyperglycaemia . Diabetes Care 2002;25:989-9.

43.

Spijkerman AMW , Yuyun MF , Griffin SJ et al. The performance of a risk score as a screening test for undiagnosed hyperglycaemia in ethnic minority groups. Data from the 1999 Health Survey for England . Diabetes Care 2004;27:116-22.

44.

Ramachandran A. , Snehalatha C. , Vijay V. et al. Derivation and validation of diabetes risk score for urban Asian Indians. Diabetes Res Clin Pract 2005;70:63-70.

45.

Vyas A. , Haidery AZ , Wiles PG et al. A pilot randomised trial in primary care to investigate and improve knowledge, awareness and self-management among South Asians with diabetes in Manchester. Diabetic Med 2003;20:1022-6.

46.

Grace C. , Begum R. , Subhani S. et al. Diabetes prevention: attitudes and perceptions about the role of physical activity in a British Bangladeshi community. Diabetic Med 2006;23(suppl 2):P384.

47.

Grace C. , Begum R. , Subhani S. et al. Diabetes prevention: tensions and ambiguities in the perceptions of a British Bangladeshi population. Diabetic Med 2006;23(suppl 2):P385.

48.

Salonen JT , Puska P. , Mustaniemi H. Changes in morbidity and mortality during comprehensive five-year community programme to control cardiovascular disease (North Karelia Project) . BMJ 1979;2:1173-8.